For many years hypoplastic or aplastic anemia has been identified with a confusing group of pancytopenias which are refractory to treatment. Recently The Committee for Clarification of the Nomenclature of Cells and Diseases of the Blood and Blood-forming Organs has redefined the term hypoplastic anemia and discarded the term aplastic anemia."3 Hypoplastic anemia is defined by this committee as a pancytopenia caused by actual hypocellularity of the bone marrow. This definition probably embraces many diseases with different etiologies but it does place in a single category all cases of pancytopenia due to hypocellularity of the bone marrow.
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In most reports of pancytopenias which are refractory to treatment no clear differentiation has been made between cases with hypocellularity and those with hypercellularity of the marrow. This fact makes it hard to draw conclusions concerning the etiology and prognosis of true hypoplastic anemia. There seem to be two distinct types of hypoplastic anemia. One is acute and fulminating and usually is associated with a definite history of exposure to an agent toxic for bone marrow. Avoidance of exposure to this agent not infrequently is followed by spontaneous recovery. The other type is chronic and slowly progressive over a period of months or years. In most of the chronic cases it is not possible to obtain a history of significant exposure to toxins. Recovery from the chronic type of hypoplastic anemia occurs only rarely and unpredictably and apparently is spontaneous rather than due to any specific treatment. No agent has been found which will induce regeneration of the bone marrow in acute or chronic hypoplastic anemia.
Soon after the introduction of cortisone and ACTH in the treatment of a variety of diseases it was discovered that they would often correct a complicating anemia or leukopenia. These findings suggested that cortisone and ACTH had a stimulatory effect on hematopoiesis and might be useful in the treatment of hypoplastic anemia. 2 The response of normal bone marrow to cortisone and ACTH has not been fully evaluated. Hills"0 and Forsham7 reported a moderate neutrophilic leukocytosis in normal individuals four hours after a single dose of ACTH but this observation can hardly be interpreted as evidence for stimulation of bone marrow. Administration of ACTH over a period of several days, however, produced a marked neutrophilia in two normal volunteers.10 On the other hand, there have been no reports of significant changes in the number of reticulocytes, red blood cells, and platelets or in the bone marrow of normal individuals following administration of ACTH or cortisone. The eosinopenic effect of cortisone and ACTH probably is unrelated to bone marrow function.6
Although cortisone and ACTH have frequently corrected a mild complicating anemia or leukopenia in patients with chronic rheumatoid arthritis6"8 or disseminated lupus erythematosis,15 this response usually has been associated with general improvement in the signs and symptoms of the underlying disease. In patients with severe hematological diseases such as acute leukemia,3'11 idiopathic thrombocytopenia purpura,8 agranulocytosis,l and acquired hemolytic anemia,' the effect of ACTH or cortisone has occasionally been striking and has produced an almost complete reversal of the bone marrow to normal. However, in both instances it has been felt that the hematological remissions were not due to a direct stimulating effect of the hormones on the bone marrow, but rather to a suppression of the underlying disorder.
Yet it seems possible that cortisone and ACTH may have a direct stimulating effect on bone marrow. Hill and Hunter9 have reported four cases of refractory anemia with isolated hypoplasia of the erythropoietic tissue where ACTH caused a dramatic remission in one case and delayed, more questionable remissions in the other three. In the discussion of their paper, four similar cases were reported, all of whom responded well to ACTH. A small but definite leukocytosis and reticulocytosis were seen in all of twenty cases of diffuse collagen diseases treated by S. C. Finch. Rosenberg has reported leukocytosis up to 20,000-25,000 in some cases following the administration of corticotrophins.'2 Furthermore, spontaneous adrenal hyperactivity, such as is seen in Cushing's disease, usually is accompanied by leukocytosis,5 and occasionally by a true polycythemia. ' In order to test the effect of cortisone or ACTH on an inactive hypoplastic bone marrow six cases of hypoplastic anemia were treated with these hormones.
MATERIALS AND METHODS
The cases presented were admitted for study to the Grace-New Haven Community Hospital during the past year. Each patient had a marked leukopenia, thrombocytopenia, and normochromic anemia. Bone marrow aspirations and biopsies revealed fatty replacement of the marrows, with a relative increase in the number of lymphocytes and plasma cells. Five cases were diagnosed as having chronic hypoplastic anemia, while one case (IV) had acute hypoplastic anemia. In one of the chronic cases (V) and in the acute case (IV) there were histories of brief exposure to subtoxic doses of benzol many months prior to the onset of symptoms. Case VI (reported through the courtesy of Dr. David H. Clement) a young boy, aged seven, also had multiple congenital malformations which suggested a diagnosis of Fanconi's syndrome. However, the pancytopenia had not been present before the age of three (Table 1) . V there was a definite but temporary rise in the number of leukocytes, platelets, and reticulocytes, but repeated bone marrow aspirations and one bone marrow biopsy did not reveal the slightest increase in activity (Graph 3). In cases II, III, and VI a moderate but short lasting rise in the number of neutrophilic leukocytes occurred and in case I there was a rise in the number of reticulocytes (Graphs 1, 2, and 3) . However, the bone marrows in all cases remained hypoplastic without exhibiting signs of regeneration. The purpuric tendencies, increased capillary fragilities, or prolonged bleeding times were not altered by treatment in any of the six cases.
DIscUSSION
In the last few years cortisone and ACTH have been used more or less empirically in the treatment of many diseases. Hematological remissions have been reported in a number of these, such as acute leukemia, diffuse collagen diseases, agranulocytosis, refractory anemia, acquired hemolytic anemia and essential thrombocytopenic purpura. A polymorphonuclear leukocytosis and a reticulocytosis have also been observed in many patients during treatment. These observations led to the suggestion that ACTH and cortisone exert a direct effect on hematopoietic tissue and might be of value in the treatment of patients with a deficiency in function of the bone marrow such as that which occurs in patients with hypoplastic anemia.' Assuming that the bone marrow in chronic hypoplastic anemia is merely inactive and not irrevocably damaged, the results in the five cases presented here strongly suggest that cortisone and ACTH have no direct stimulating action on bone marrow. The hematological remissions described following treatment with ACTH and cortisone in a number of diseases were probably the result of more normal conditions which prevailed after a primary disorder had been corrected, rather than the result of a direct stimulation of the marrow. The sustained leukocytosis and reticulocytosis observed in some cases treated with these hormones cannot be explained at present. SUMMARY . Five cases of chronic and one case of acute hypoplastic anemia were treated with cortisone or ACTH for from 7 to 20 days. No significant changes were observed in the hypoplastic bone marrows. Aside from small, temporary changes in the leukocyte and reticulocyte counts, the pancytopenia continued unchecked.
